Tikun Olam Cannbit Pharmaceuticals Ltd Working Capital to Net Assets Ratio
Tikun Olam Cannbit Pharmaceuticals Ltd working capital to net assets ratio. Tikun Olam Cannbit Pharmaceuticals Ltd (TKUN) has a Working Capital to Net Assets ratio of 83.2% as of June 2025. Working capital of ILA-16.35 Million (current assets of ILA4.04 Million minus current liabilities of ILA20.40 Million) is measured against net assets of ILA-19.66 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check TKUN tangible net worth ratio to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Tikun Olam Cannbit Pharmaceuticals Ltd (2017–2024)
Working capital to net assets ratio of Tikun Olam Cannbit Pharmaceuticals Ltd from 2017 to 2024. This chart shows how Tikun Olam Cannbit Pharmaceuticals Ltd's Working Capital to Net Assets ratio has evolved across 8 annual periods from 2017 to 2024. As of June 2025, the ratio stands at 83.2%, reflecting working capital of ILA-16.35 Million against net assets of ILA-19.66 Million ILA. See Tikun Olam Cannbit Pharmaceuticals Ltd defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
Tikun Olam Cannbit Pharmaceuticals Ltd Working Capital to Net Assets Ratio by Year (2017–2024)
Tikun Olam Cannbit Pharmaceuticals Ltd working capital to net assets ratio by year from 2017 to 2024. The table below presents the year-by-year Working Capital to Net Assets ratio for Tikun Olam Cannbit Pharmaceuticals Ltd from 2017 to 2024, covering 8 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see TKUN total assets.
| Year | WC/NA Ratio | Working Capital (ILA) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 251.8% | ILA-13.46 Million | ILA-5.35 Million | ILA6.47 Million | ILA19.94 Million | ▲ +264.6 pp |
| 2023 | -12.8% | ILA-4.23 Million | ILA33.04 Million | ILA24.10 Million | ILA28.33 Million | ▼ -26.7 pp |
| 2022 | 13.9% | ILA16.25 Million | ILA116.92 Million | ILA43.46 Million | ILA27.21 Million | ▲ +0.0 pp |
| 2021 | 13.9% | ILA19.95 Million | ILA143.82 Million | ILA42.93 Million | ILA22.97 Million | ▲ +3.0 pp |
| 2020 | 10.8% | ILA14.75 Million | ILA136.06 Million | ILA41.18 Million | ILA26.43 Million | ▲ +18.9 pp |
| 2019 | -8.0% | ILA-8.02 Million | ILA99.87 Million | ILA14.23 Million | ILA22.24 Million | ▼ -1280.2 pp |
| 2018 | 1272.2% | ILA1.37 Million | ILA108.00K | ILA3.09 Million | ILA1.71 Million | ▲ +1431.6 pp |
| 2017 | -159.3% | ILA784.00K | ILA-492.00K | ILA831.00K | ILA47.00K | — |